description: a pharmacologist known for refusing FDA approval of thalidomide, preventing a US tragedy
8 results
by Linsey McGoey · 14 Sep 2019
by Grünenthal and its UK licensee even after early signs of birth defects were apparent.5 In the United States, an FDA drug examiner named Frances Oldham Kelsey grew concerned by reports of birth defects in Europe and Australia. Supported by many of her colleagues and superiors, she refused to approve the drug
…
woman who stood between America and a generation of “Thalidomide babies”’ (Smithsonian.com, May 8). 9 Quoted in Ward, ‘Frances Kelsey.’ 10 Robert McFadden, 2015. ‘Frances Oldham Kelsey, who saved U.S. babies from Thalidomide, dies at 101’ (The New York Times, August 7). 11 Benjamin Kentish, 2016. ‘Donald Trump could be like
by William Rosen · 14 Apr 2017 · 515pp · 117,501 words
. And so it might have, but for a scandal more gruesome, and more notorious, than the Elixir Sulfanilamide and aplastic anemia scares combined. — In 1962, Frances Oldham Kelsey had been balancing the costs and benefits of the antibiotic revolution for nearly twenty-five years. In 1938, with the ink barely dry on her
…
assure the safety, effectiveness, and reliability of drugs,” was signed into law by President John Kennedy. Standing behind him for the traditional signing photo was Frances Oldham Kelsey. — Kefauver-Harris wasn’t the first major piece of federal legislation to recognize that the world of medicine had been utterly transformed since 1938. In
…
, for the first time, a clear distinction between prescription drugs and those sold directly to patients. Credit: National Institutes of Health/National Library of Medicine Frances Oldham Kelsey (1914–2015) receiving the President’s Award for Distinguished Federal Civilian Service from President John F. Kennedy Until the 1950s, the decision to classify a
by Vincent T. Devita, Jr., M. D. and Elizabeth Devita-Raeburn · 3 Nov 2015 · 386pp · 114,405 words
, eds., Cancer Control Objectives for the Nation: 1985–2000, National Cancer Institute Monographs 2 (Bethesda, Md.: National Cancer Institute, 1986). 8. Frances Kelsey Syndrome 1. Frances Oldham Kelsey, Chemical Heritage Foundation, www.chemheritage.org/discover/online-resources/chemistry-in-history/themes/public-and-environmental-health/food-and-drug-safety/kelsey.aspx. 2. Morton
by Abigail Shrier · 28 Jun 2020 · 345pp · 87,534 words
’t have a leg to stand on.” Katherine eventually founded the Kelsey Coalition, an organization devoted to opposing transgender ideology; it’s named for Dr. Frances Oldham Kelsey who, back in 1960, had warned the world of the dangers of thalidomide. Katherine has also drafted legislation that would make it illegal for adults
by Katherine Eban · 13 May 2019 · 510pp · 141,188 words
1941 Sulfathiazole Disaster and the Birth of Good Manufacturing Practices,” Pharmacy in History 40, no. 1 (1999). to sell a drug called Kevadon: Linda Bren, “Frances Oldham Kelsey: FDA Medical Reviewer Leaves Her Mark on History,” U.S. Food and Drug Administration, FDA Consumer (March/April 2001), http://web.archive.org/web/20061020043712
by Benjamin Breen · 16 Jan 2024 · 384pp · 118,573 words
be male, sexism and racism profoundly shaped midcentury drug research. The thalidomide scandal, which had in part been uncovered by a female FDA employee named Frances Oldham Kelsey, signaled a new awareness of that bias. Influenced by the civil rights movement and the first stirrings of second-wave feminism, medical and drug researchers
by Brian Christian · 5 Oct 2020 · 625pp · 167,349 words
before the drug was taken off the market.8 (Americans were largely spared, as a result of a skeptical Food and Drug Administration employee, Dr. Frances Oldham Kelsey.) In the case of “supervised learning,” where the training data is “labeled” in some fashion, we need to consider critically, too, not only where we
by Erik Vance · 14 Sep 2016 · 266pp · 85,265 words
changed the public image of the pharmaceutical industry. The drug was never available in the United States (thanks largely to the heroically skeptical FDA doctor Frances Oldham Kelsey), but by 1962 the U.S. public was deeply shaken and demanded safeguards against the possibility that such a dangerous drug could be available here